Dovitinib in Neuroendocrine Tumors

Clinical trial NCT01635907 · COMPLETED

Trial details

NCT number: NCT01635907
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Metastatic Paraganglioma Advanced Metastatic Pheochromocytoma Recurrent Paraganglioma Recurrent Pheochromocytoma Unresectable Paraganglioma Unresectable Pheochromocytoma

Start date: 2012-06-01
Primary completion: 2016-03-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.